{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:34:26Z","timestamp":1791279266026,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.patbio.2008.03.001","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T18:30:52Z","timestamp":1210098652000},"page":"233-238","source":"Crossref","is-referenced-by-count":3,"title":["Les anticoagulants allongent-ils la survie des patients canc\u00e9reux\u00a0?"],"prefix":"10.1016","volume":"56","author":[{"given":"G.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.patbio.2008.03.001_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1657512","article-title":"Venous thromboembolism and cancer: a two-way clinical association","volume":"78","author":"Agnelli","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl. 3","key":"10.1016\/j.patbio.2008.03.001_bib2","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1378\/chest.124.3_suppl.58S","article-title":"Tissue factor, thrombin, and cancer","volume":"124","author":"Rickles","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.patbio.2008.03.001_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.0.CO;2-Z","article-title":"Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis","volume":"79","author":"Koomagi","year":"1998","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.patbio.2008.03.001_bib4","first-page":"683","article-title":"Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anticancer efficacy","volume":"12","author":"Mousa","year":"2004","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/j.patbio.2008.03.001_bib5","first-page":"3267","article-title":"Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo","volume":"52","author":"Nierodzik","year":"1992","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.patbio.2008.03.001_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI114976","article-title":"Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo","volume":"87","author":"Nierodzik","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.patbio.2008.03.001_bib7","first-page":"305","article-title":"Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition","volume":"948","author":"Nagy","year":"1989","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.patbio.2008.03.001_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.74.3.525","article-title":"Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis","volume":"74","author":"Bennett","year":"1994","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.patbio.2008.03.001_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/cbir.1993.1140","article-title":"Antiproliferative effects of heparin on normal and transformed NIH\/3T3 fibroblasts","volume":"17","author":"Cavari","year":"1993","journal-title":"Cell Biol Int"},{"issue":"6","key":"10.1016\/j.patbio.2008.03.001_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2184.1996.tb01582.x","article-title":"Growth factors and apoptosis","volume":"29","author":"Granerus","year":"1996","journal-title":"Cell Prolif"},{"issue":"6","key":"10.1016\/j.patbio.2008.03.001_bib11_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1054\/mehy.2000.1093","article-title":"Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu","volume":"55","author":"Lwaleed","year":"2000","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.patbio.2008.03.001_bib11_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.10061","article-title":"Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer","volume":"69","author":"Nakasaki","year":"2002","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.patbio.2008.03.001_bib12","first-page":"627","article-title":"Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor","volume":"92","author":"Mousa","year":"2004","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.patbio.2008.03.001_bib13","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1046\/j.1538-7836.2003.00341.x","article-title":"Antimetastatic effect of tinzaparin, a low-molecular-weight heparin","volume":"1","author":"Amirkhosravi","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.patbio.2008.03.001_bib14","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.patbio.2008.03.001_bib15","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1158\/0008-5472.CAN-03-1054","article-title":"Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis","volume":"64","author":"Ludwig","year":"2004","journal-title":"Cancer Res"},{"issue":"19 Pt 1","key":"10.1016\/j.patbio.2008.03.001_bib16","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-05-1131","article-title":"Differential metastasis inhibition by clinically relevant levels of heparins\u2013correlation with selectin inhibition, not antithrombotic activity","volume":"11","author":"Stevenson","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.patbio.2008.03.001_bib17","first-page":"1411","article-title":"In vitro effects of heparin on SW480 tumor cell-matrix interaction","volume":"15","author":"Antachopoulos","year":"1995","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.patbio.2008.03.001_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00001721-199710000-00005","article-title":"Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase","volume":"8","author":"Bertolesi","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1\u20136","key":"10.1016\/j.patbio.2008.03.001_bib19","first-page":"290","article-title":"Inhibition of tumor metastasis by heparanase inhibiting species of heparin","volume":"14","author":"Vlodavsky","year":"1994","journal-title":"Invasion Metastasis"},{"issue":"5","key":"10.1016\/j.patbio.2008.03.001_bib20_1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1172\/JCI117191","article-title":"Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells","volume":"93","author":"Kenagy","year":"1994","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.patbio.2008.03.001_bib20_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion","volume":"13","author":"Westermarck","year":"1999","journal-title":"Faseb J."},{"issue":"4","key":"10.1016\/j.patbio.2008.03.001_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0049-3848(03)00296-2","article-title":"Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy","volume":"110","author":"Pross","year":"2003","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.patbio.2008.03.001_bib22","first-page":"1586","article-title":"The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis","volume":"86","author":"Smorenburg","year":"2001","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.patbio.2008.03.001_bib23","first-page":"1600","article-title":"The effects of unfractionated heparin on survival in patients with malignancy\u2013a systematic review","volume":"82","author":"Smorenburg","year":"1999","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.patbio.2008.03.001_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E","article-title":"Subcutaneous heparin treatment increases survival in small cell lung cancer. \u201cPetites Cellules\u201d Group","volume":"74","author":"Lebeau","year":"1994","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.patbio.2008.03.001_bib25_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-130-10-199905180-00002","article-title":"Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis","volume":"130","author":"Gould","year":"1999","journal-title":"Ann Intern Med"},{"issue":"8807","key":"10.1016\/j.patbio.2008.03.001_bib25_2","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/0140-6736(92)92064-M","article-title":"Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin","volume":"339","author":"Green","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.patbio.2008.03.001_bib26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.patbio.2008.03.001_bib27","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1200\/JCO.2004.10.002","article-title":"Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)","volume":"22","author":"Kakkar","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.patbio.2008.03.001_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1538-7836.2004.00871.x","article-title":"A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer","volume":"2","author":"Altinbas","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.patbio.2008.03.001_bib29","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1200\/JCO.2005.03.134","article-title":"The effect of low molecular weight heparin on survival in patients with advanced malignancy","volume":"23","author":"Klerk","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.patbio.2008.03.001_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.patbio.2008.03.001_bib31","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2005.03.133","article-title":"Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T04:27:00Z","timestamp":1557548820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811408000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0369811408000485"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2008.03.001","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}